Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2008 December;60(6) > Minerva Pediatrica 2008 December;60(6):1417-35

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,764


eTOC

 

REVIEWS  


Minerva Pediatrica 2008 December;60(6):1417-35

Copyright © 2008 EDIZIONI MINERVA MEDICA

language: English

Metchnikoff and the centenary of probiotics: an update of their use in gastroenteric pathology during the age of development

Caramia G.

Emeritus Head of Neonatology and Pediatric Department Specialized Pediatric Hospital “G. Salesi” Ancona, Italy


PDF  


Acute gastroenteritis, antibiotic-associated diarrhea, diarrhea due to Clostridium difficile and traveller’s diarrhea, Helicobacter pylori infection and intestinal inflammatory diseases are primitive and/or secondary pathological conditions that alter the intestinal mucosa and microbiota. For years researchers have searched for solutions to restore and rebalance normal transit and intestinal flora. Elia Metchnikoff was the first one to introduce oral bacteriotherapy, that uses very efficient microorganisms that prevent putrefaction and aging. Oral bacteriotherapy has now evolved in probiotics, whose helpful action to prevent and treat some gastroenteric pathologies is currently being studied.

top of page

Publication History

Cite this article as

Corresponding author e-mail